Gene targeting: methods, applications, and types

How it works

Historically, gene targeting relied on homologous recombination in cells that could incorporate introduced DNA into the chromosome. Modern practice often induces a site‑specific DNA break using engineered nucleases (zinc‑finger nucleases, TALENs, or CRISPR/Cas systems), then provides a repair template so the cell’s repair machinery installs the designed alteration. These steps reduce random integration and increase the frequency of correctly modified alleles in various model organisms.

Types and conditional strategies

Common outcomes of gene targeting include complete gene disruption (knockout), precise replacement (knock‑in), small substitutions (point mutations), or insertion of reporters and selection markers. Conditional targeting confines changes to particular tissues or times: systems such as site‑specific recombinases and inducible promoters let researchers turn gene modifications on or off in defined contexts, avoiding developmental lethality or broad pleiotropic effects.

Typical workflow

A typical experiment involves designing a repair construct with homology arms, delivering that construct and nuclease components to cells or embryos, applying selection and screening to identify correctly edited clones, and validating the change at DNA, RNA, and protein levels. Techniques and delivery vary by species; for example, insect genetics in Drosophila use different vectors and screens than mammalian embryonic stem cell approaches.

Applications and examples

• Basic research: define gene function by creating precise mutations in mice or rats.
• Agriculture: introduce traits in plants such as tobacco or corn to study resistance or metabolism.
• Biomedical science: modify human cells in culture to model disease mechanisms, screen drugs, or explore therapeutic strategies.

Limitations and considerations

Gene targeting is powerful but not without limitations: efficiency may be low in some cell types, off‑target changes can complicate interpretation, and germline editing raises ethical and regulatory questions. Careful experimental design, rigorous validation, and appropriate controls are essential. As editing tools improve, gene targeting continues to expand the repertoire of experimental models and translational possibilities.